minoxidil has been researched along with Incontinentia Pigmenti Achromians in 3 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Anderson, ZT | 1 |
Palmer, JW | 1 |
Idris, MI | 1 |
Villavicencio, KM | 1 |
Le, G | 1 |
Cowart, J | 1 |
Weinstein, DE | 1 |
Harris, ML | 1 |
Herxheimer, A | 1 |
Young, N | 1 |
Rebora, A | 1 |
Guarrera, M | 1 |
3 other studies available for minoxidil and Incontinentia Pigmenti Achromians
Article | Year |
---|---|
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation-induced canities.
Topics: Administration, Topical; Animals; Cyclosporine; Dermatologic Agents; Disease Models, Animal; Drug Co | 2021 |
Duty to warn about likely adverse effects.
Topics: Female; Humans; Hypertension; Hypertrichosis; Malpractice; Middle Aged; Minoxidil; Patient Education | 1990 |
Hair discoloration caused by minoxidil lotion.
Topics: Administration, Topical; Aged; Female; Hair Diseases; Humans; Minoxidil; Pigmentation Disorders | 1989 |